Aspire Private Capital’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-26
| Closed | -$9.32K | – | 605 |
|
|
2024
Q3 | $9.32K | Hold |
26
| – | – | ﹤0.01% | 390 |
|
|
2024
Q2 | $8.28K | Hold |
26
| – | – | ﹤0.01% | 405 |
|
|
2024
Q1 | $5.97K | Hold |
26
| – | – | ﹤0.01% | 464 |
|
|
2023
Q4 | $5.72K | Hold |
26
| – | – | ﹤0.01% | 455 |
|
|
2023
Q3 | $5.87K | Hold |
26
| – | – | ﹤0.01% | 462 |
|
|
2023
Q2 | $5.74K | Hold |
26
| – | – | ﹤0.01% | 434 |
|
|
2023
Q1 | $5.82K | Sell |
26
-3
| -10% | -$672 | ﹤0.01% | 421 |
|
|
2022
Q4 | $8.07K | Hold |
29
| – | – | ﹤0.01% | 379 |
|
|
2022
Q3 | $6K | Sell |
29
-2
| -6% | -$414 | ﹤0.01% | 408 |
|
|
2022
Q2 | $7K | Hold |
31
| – | – | ﹤0.01% | 377 |
|
|
2022
Q1 | $6K | Hold |
31
| – | – | ﹤0.01% | 389 |
|
|
2021
Q4 | $7K | Sell |
31
-2
| -6% | -$452 | ﹤0.01% | 383 |
|
|
2021
Q3 | $6K | Hold |
33
| – | – | ﹤0.01% | 370 |
|
|
2021
Q2 | $6K | Sell |
33
-2
| -6% | -$364 | ﹤0.01% | 378 |
|
|
2021
Q1 | $6K | Buy |
35
+33
| +1,650% | +$5.66K | ﹤0.01% | 373 |
|
|
2020
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 536 |
|
|
2020
Q3 | $0 | Sell |
2
-35
| -95% | – | ﹤0.01% | 514 |
|
|
2020
Q2 | $4K | Buy |
+37
| New | +$4K | ﹤0.01% | 245 |
|